ARL3 and carcinoma: Immunohistochemical profiling also revealed distinct subcellular localization patterns; luminal carcinomas exhibited predominant cytoplasmic ARL3 accumulation, contrasting with minimal expression in triple‐negative tumors (Figure 1J,K).